Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Mease

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Annals of Internal Medicine|June 1, 1995
The eosinophilia-myalgia syndrome: status of 205 patients and results of treatment 2 years after onsetP A Hertzman, D J Clauw, L D Kaufman, et al.
Annals of the Rheumatic Diseases|November 19, 2008
Efficacy and safety of certolizumab pegol plus methotrexate in active rheumatoid arthritis: the RAPID 2 study. A randomised controlled trialJ Smolen, R B Landewé, P Mease, et al.
RMD Open|October 29, 2015
Effect of certolizumab pegol over 96 weeks in patients with psoriatic arthritis with and without prior antitumour necrosis factor exposureP Mease, A Deodhar, R Fleischmann, et al.
Annals of the Rheumatic Diseases|November 16, 2014
The JAK inhibitor tofacitinib suppresses synovial JAK1-STAT signalling in rheumatoid arthritisD L Boyle, K Soma, J Hodge, et al.
Annals of the Rheumatic Diseases|November 21, 2007
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2007D E Furst, F C Breedveld, J R Kalden, et al.
Annals of the Rheumatic Diseases|June 7, 2013
Treating axial and peripheral spondyloarthritis, including psoriatic arthritis, to target: results of a systematic literature search to support an international treat-to-target recommendation in spondyloarthritisM M Schoels, J Braun, M Dougados, et al.
Annals of the Rheumatic Diseases|March 31, 2012
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2011D E Furst, E C Keystone, J Braun, et al.
Annals of the Rheumatic Diseases|February 23, 2011
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010D E Furst, E C Keystone, J Braun, et al.
Annals of the Rheumatic Diseases|December 17, 2008
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2008D E Furst, E C Keystone, B Kirkham, et al.
Annals of the Rheumatic Diseases|December 10, 2009
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2009D E Furst, E C Keystone, R Fleischmann, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Annals of Internal Medicine|June 1, 1995
The eosinophilia-myalgia syndrome: status of 205 patients and results of treatment 2 years after onsetP A Hertzman, D J Clauw, L D Kaufman, et al.
Annals of the Rheumatic Diseases|November 19, 2008
Efficacy and safety of certolizumab pegol plus methotrexate in active rheumatoid arthritis: the RAPID 2 study. A randomised controlled trialJ Smolen, R B Landewé, P Mease, et al.
RMD Open|October 29, 2015
Effect of certolizumab pegol over 96 weeks in patients with psoriatic arthritis with and without prior antitumour necrosis factor exposureP Mease, A Deodhar, R Fleischmann, et al.
Annals of the Rheumatic Diseases|November 16, 2014
The JAK inhibitor tofacitinib suppresses synovial JAK1-STAT signalling in rheumatoid arthritisD L Boyle, K Soma, J Hodge, et al.
Annals of the Rheumatic Diseases|November 21, 2007
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2007D E Furst, F C Breedveld, J R Kalden, et al.
Annals of the Rheumatic Diseases|June 7, 2013
Treating axial and peripheral spondyloarthritis, including psoriatic arthritis, to target: results of a systematic literature search to support an international treat-to-target recommendation in spondyloarthritisM M Schoels, J Braun, M Dougados, et al.
Annals of the Rheumatic Diseases|March 31, 2012
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2011D E Furst, E C Keystone, J Braun, et al.
Annals of the Rheumatic Diseases|February 23, 2011
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010D E Furst, E C Keystone, J Braun, et al.
Annals of the Rheumatic Diseases|December 17, 2008
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2008D E Furst, E C Keystone, B Kirkham, et al.
Annals of the Rheumatic Diseases|December 10, 2009
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2009D E Furst, E C Keystone, R Fleischmann, et al.
Pageof 3